Skip to main content

Table 2 Clinical outcomes and complications

From: Palliative enteral feeding for patients with malignant esophageal obstruction: a retrospective study

  NG tube Esophageal stent NPO P-value
  (n = 12) (n = 10) (n = 9)  
Albumin, g/dL 3.1 ± 0.5 3.0 ± 0.5 2.1 ± 0.4 <0.01
EN intake, dL/day 11.8 ± 4.9 10.9 ± 3.5 3.6 ± 1.9 0.01
IV fluid volume, dL/day 9.9 ± 4.9 9.4 ± 3.7 13.5 ± 3.3 0.08
LOH, days 19 ± 15 12 ± 11 39 ± 18 0.01
Survival, days 122a 133a 51 <0.01
Complications 22 21 9  
 Aspiration pneumonia 7b 5b 9 0.38
 Dislodgment 7c 2c 0 0.01
 Chest pain 2 3 0 0.21
 Perforation 0 0 0  
 Hemorrhage 0 0 0  
  1. ap = 0.56 between NG tube group and esophageal stent group. bp = 0.63 between NG tube group and esophageal stent group. cp = 0.01 between NG tube group and esophageal stent group. NG tube nasogastric tube, NPO nil per os, EN enteral nutrition, PN parenteral nutrition, LOH length of hospital stay, IV intravenous